Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Hansoh Pharmaceuticals

    regeneron headquarters

    Regeneron’s Lynozyfic granted FDA accelerated approval to treat multiple myeloma

    More than 36,000 new cases of the blood cancer are expected to be diagnosed in the US this year

    - PMLiVE

    Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa

    The company is planning to submit regulatory applications for the candidate by the end of the year

    regeneron headquarters

    Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn

    The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

    regeneron headquarters

    Regeneron to acquire human genetics company 23andMe for $256m

    The agreement comes two months after 23andMe filed for bankruptcy protection

    regeneron headquarters

    Regeneron receives positive CHMP opinion for linvoseltamab in multiple myeloma

    More than 35,000 new cases of the blood cancer are diagnosed every year in Europe

    regeneron headquarters

    Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer

    Approximately 1.8 million cases of cutaneous squamous cell carcinoma are diagnosed in the US every year

    - PMLiVE

    Eli Lilly announces $3bn expansion to US injectables manufacturing facility

    The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

    - PMLiVE

    Sanofi unveils plans to build €1bn insulin production base in China

    The site will focus on serving the insulin medication needs of local diabetic patients

    - PMLiVE

    Common antidiabetic drug metformin found to slow growth of precancerous cells

    The findings suggest that the drug could be used to manage squamous oesophageal cancer risk

    - PMLiVE

    Eli Lilly’s once-weekly insulin candidate shows promise in late-stage diabetes trials

    It is hoped that a once-weekly treatment option could improve adherence rates

    - PMLiVE

    Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

    Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

    Medscape Education

    regeneron headquarters

    Regeneron’s odronextamab recommended by CHMP to treat certain lymphomas

    Follicular lymphoma and diffuse large B-cell lymphoma are collectively responsible for an estimated 283,000 global cases every year

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links